Hao Tian Management Faces Forced Sale of Shares, Reducing Stake in HTICI to 10.27%

Reuters

07/14

Hao Tian Management Faces Forced Sale of Shares, Reducing Stake in HTICI to 10.27%

Hao Tian Management (Hong Kong) Limited, an indirect wholly-owned subsidiary of Aceso Life Science Group Limited, recently experienced a forced sale of its shares in Hao Tian International Construction Investment Group Limited. The forced sale, executed by an independent third-party lender, was triggered after a default event related to a loan facility of HK$150 million. In total, 1,385,116,000 shares were sold at an average price of HK$0.37855 per share, generating gross proceeds of approximately HK$524,336,000. These proceeds will be used to repay the outstanding loan and accrued interest of approximately HK$151 million, with any remaining balance returned to Hao Tian Management. As a result of this transaction, Aceso Life Science Group's shareholding in Hao Tian International Construction Investment Group Limited has decreased from 28.16% to 10.27%.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aceso Life Science Group Ltd. published the original content used to generate this news brief on July 14, 2025, and is solely responsible for the information contained therein.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2551507182"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2551507182\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2551507182?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-07-14 22:19","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2551507182","market":"nz","top_or_hot":-1,"title":"Hao Tian Management Faces Forced Sale of Shares, Reducing Stake in HTICI to 10.27%","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Hao Tian Management Faces Forced Sale of Shares, Reducing Stake in HTICI to 10.27%\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Hao Tian Management (<a href=\"https://laohu8.com/S/HKRHF\">Hong Kong</a>) Limited, an indirect wholly-owned subsidiary of Aceso Life Science Group Limited, recently experienced a forced sale of its shares in Hao Tian International Construction Investment Group Limited. The forced sale, executed by an independent third-party lender, was triggered after a default event related to a loan facility of HK$150 million. In total, 1,385,116,000 shares were sold at an average price of HK$0.37855 per share, generating gross proceeds of approximately HK$524,336,000. These proceeds will be used to repay the outstanding loan and accrued interest of approximately HK$151 million, with any remaining balance returned to Hao Tian Management. As a result of this transaction, Aceso Life Science Group's shareholding in Hao Tian International Construction Investment Group Limited has decreased from 28.16% to 10.27%.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aceso Life Science Group Ltd. published the original content used to generate this news brief on July 14, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hao Tian Management Faces Forced Sale of Shares, Reducing Stake in HTICI to 10.27%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHao Tian Management Faces Forced Sale of Shares, Reducing Stake in HTICI to 10.27%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-07-14 22:19</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Hao Tian Management Faces Forced Sale of Shares, Reducing Stake in HTICI to 10.27%\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Hao Tian Management (<a href=\"https://laohu8.com/S/HKRHF\">Hong Kong</a>) Limited, an indirect wholly-owned subsidiary of Aceso Life Science Group Limited, recently experienced a forced sale of its shares in Hao Tian International Construction Investment Group Limited. The forced sale, executed by an independent third-party lender, was triggered after a default event related to a loan facility of HK$150 million. In total, 1,385,116,000 shares were sold at an average price of HK$0.37855 per share, generating gross proceeds of approximately HK$524,336,000. These proceeds will be used to repay the outstanding loan and accrued interest of approximately HK$151 million, with any remaining balance returned to Hao Tian Management. As a result of this transaction, Aceso Life Science Group's shareholding in Hao Tian International Construction Investment Group Limited has decreased from 28.16% to 10.27%.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aceso Life Science Group Ltd. published the original content used to generate this news brief on July 14, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1188","symbol_name":"消费信贷","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250714:nNDL8S0Xqc:1","article_id":"2551507182","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2551507182","pubTimestamp":1752502740,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Hao Tian Management  Limited, an indirect wholly-owned subsidiary of Aceso Life Science Group Limited, recently experienced a forced sale of its shares in Hao Tian International Construction Investment Group Limited. The forced sale, executed by an independent third-party lender, was triggered after a default event related to a loan facility of HK$150 million. In total, 1,385,116,000 shares were sold at an average price of HK$0.37855 per share, generating gross proceeds of approximately HK$524,336,000. These proceeds will be used to repay the outstanding loan and accrued interest of approximately HK$151 million, with any remaining balance returned to Hao Tian Management. As a result of this transaction, Aceso Life Science Group's shareholding in Hao Tian International Construction Investment Group Limited has decreased from 28.16% to 10.27%.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate an","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1188":"消费信贷","01341":"昊天国际建投","00474":"信铭生命科技"},"translate_title":"昊天管理层面临强制售股减持HTICI股份至10.27%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00474":0.9,"01341":0.9},"content_text":"Hao Tian Management Faces Forced Sale of Shares, Reducing Stake in HTICI to 10.27%\n    \n\n        Hao Tian Management (Hong Kong) Limited, an indirect wholly-owned subsidiary of Aceso Life Science Group Limited, recently experienced a forced sale of its shares in Hao Tian International Construction Investment Group Limited. The forced sale, executed by an independent third-party lender, was triggered after a default event related to a loan facility of HK$150 million. In total, 1,385,116,000 shares were sold at an average price of HK$0.37855 per share, generating gross proceeds of approximately HK$524,336,000. These proceeds will be used to repay the outstanding loan and accrued interest of approximately HK$151 million, with any remaining balance returned to Hao Tian Management. As a result of this transaction, Aceso Life Science Group's shareholding in Hao Tian International Construction Investment Group Limited has decreased from 28.16% to 10.27%.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aceso Life Science Group Ltd. published the original content used to generate this news brief on July 14, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}